Global Anastomosis Devices Market is valued approximately USD 3.39billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.60% over the forecast period 2022-2028. The connecting of two typically divergent structures is known as an anastomosis. Connections between blood vessels or other tubular structures, such as gut loops, are referred to as this. In the approaching years, the increased prevalence of cardiovascular and gastrointestinal illnesses is expected to drive demand for anastomosis devices. According to the World Health Organization (WHO), 17.9 million people died from cardiovascular diseases (CVD) in 2019, accounting for 32 percent of all fatalities worldwide. It further claims that strokes and heart attacks account for 85 percent of these deaths. Coronary Heart Disease/Artery Disease (CHD/CAD) is the most common type of heart disease, with about 805,000 Americans suffering from a heart attack each year.. For example, GI Windows Corp. raised $16.4 million in a Series A-1 funding round in October 2020, with participation from Johnson & Johnson Innovation and others. The funding will be used to advance the company's anastomosis technology development and clinical studies. Furthermore, the demand for better patient outcomes will boost the adoption of novel anastomosis device advancements and contribute to market growth. For example, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic, launched the EEA Circular Stapler with Tri-Staple Technology in December 2020. This is the first 3-row Circular Stapler with a wide range of staple heights that has been approved for use in colorectal surgery. However, throughout the projection period of 2022-2028, the market's growth would be hampered by the high cost of devices and the substantial clinical data requirements for releasing new products.
The key regions considered for the global Anastomosis Devices market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Because of well-structured reimbursement regulations, a growing target population, and the presence of a significant number of essential participants on the ground, North America was in the forefront in the global arena. Due to the growing geriatric population, rising CVD incidence, rapid developments in the healthcare sector, and rising disposable income, Asia Pacific is expected to grow at a lucrative CAGR during the forecast period.
Major market player included in this report are:
MAQUET Holding B.V. & Co. KG.
Dextera Surgical Inc.
Vitalitec Internaional Inc.
Synovis Micro Companies Alliance, Inc.
Ethicon US, LLC
Johnson & Johnson
B. Braun Melsungen AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type
Ambulatory Care Centers & Clinics
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Anastomosis Devices Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers